nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ESR1—uterine fibroid	0.786	1	CbGaD
Tamoxifen—CYP19A1—corpus luteum—uterine fibroid	0.00909	0.0778	CbGeAlD
Tamoxifen—ESR2—oviduct—uterine fibroid	0.00397	0.0339	CbGeAlD
Tamoxifen—ESRRA—Nuclear Receptors—PGR—uterine fibroid	0.00311	0.0342	CbGpPWpGaD
Tamoxifen—EBP—uterine cervix—uterine fibroid	0.00284	0.0242	CbGeAlD
Tamoxifen—ESR1—oviduct—uterine fibroid	0.00272	0.0232	CbGeAlD
Tamoxifen—DHCR7—nipple—uterine fibroid	0.0025	0.0214	CbGeAlD
Tamoxifen—ESRRA—nipple—uterine fibroid	0.00246	0.0211	CbGeAlD
Tamoxifen—ESRRA—Nuclear Receptor transcription pathway—PGR—uterine fibroid	0.00246	0.027	CbGpPWpGaD
Tamoxifen—EBP—uterus—uterine fibroid	0.00236	0.0202	CbGeAlD
Tamoxifen—ESR2—Ovarian Infertility Genes—PGR—uterine fibroid	0.00227	0.025	CbGpPWpGaD
Tamoxifen—EBP—female reproductive system—uterine fibroid	0.00212	0.0182	CbGeAlD
Tamoxifen—ESRRA—myometrium—uterine fibroid	0.00211	0.0181	CbGeAlD
Tamoxifen—EBPL—female gonad—uterine fibroid	0.00202	0.0172	CbGeAlD
Tamoxifen—ESR2—Nuclear Receptors—PGR—uterine fibroid	0.00198	0.0218	CbGpPWpGaD
Tamoxifen—FMO1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.0019	0.0209	CbGpPWpGaD
Tamoxifen—Diethylstilbestrol—ESR1—uterine fibroid	0.00187	0.29	CrCbGaD
Tamoxifen—Ospemifene—ESR1—uterine fibroid	0.00181	0.282	CrCbGaD
Tamoxifen—SULT1A1—female reproductive system—uterine fibroid	0.00176	0.0151	CbGeAlD
Tamoxifen—CYP19A1—Endogenous sterols—CYP17A1—uterine fibroid	0.00168	0.0185	CbGpPWpGaD
Tamoxifen—DHCR7—uterine cervix—uterine fibroid	0.00167	0.0143	CbGeAlD
Tamoxifen—FMO1—uterine cervix—uterine fibroid	0.00167	0.0143	CbGeAlD
Tamoxifen—ESRRA—Nuclear Receptors—ESR1—uterine fibroid	0.00166	0.0183	CbGpPWpGaD
Tamoxifen—ESRRA—uterine cervix—uterine fibroid	0.00164	0.0141	CbGeAlD
Tamoxifen—CYP1B1—Endogenous sterols—CYP17A1—uterine fibroid	0.00162	0.0178	CbGpPWpGaD
Tamoxifen—ESRRA—PPARA activates gene expression—MED12—uterine fibroid	0.0016	0.0177	CbGpPWpGaD
Tamoxifen—SULT1A1—female gonad—uterine fibroid	0.0016	0.0137	CbGeAlD
Tamoxifen—SULT1A1—vagina—uterine fibroid	0.00159	0.0136	CbGeAlD
Tamoxifen—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—uterine fibroid	0.00157	0.0173	CbGpPWpGaD
Tamoxifen—ESRRA—decidua—uterine fibroid	0.00157	0.0134	CbGeAlD
Tamoxifen—ESR2—Nuclear Receptor transcription pathway—PGR—uterine fibroid	0.00156	0.0172	CbGpPWpGaD
Tamoxifen—FMO1—urethra—uterine fibroid	0.00154	0.0131	CbGeAlD
Tamoxifen—DHCR7—urethra—uterine fibroid	0.00154	0.0131	CbGeAlD
Tamoxifen—ESRRA—urethra—uterine fibroid	0.00151	0.0129	CbGeAlD
Tamoxifen—FMO1—endometrium—uterine fibroid	0.00151	0.0129	CbGeAlD
Tamoxifen—ESRRA—endometrium—uterine fibroid	0.00149	0.0127	CbGeAlD
Tamoxifen—Toremifene—ESR1—uterine fibroid	0.00148	0.23	CrCbGaD
Tamoxifen—DHCR7—mammalian vulva—uterine fibroid	0.00146	0.0125	CbGeAlD
Tamoxifen—FMO1—mammalian vulva—uterine fibroid	0.00146	0.0125	CbGeAlD
Tamoxifen—ESRRA—mammalian vulva—uterine fibroid	0.00144	0.0123	CbGeAlD
Tamoxifen—DHCR7—cardiac atrium—uterine fibroid	0.0014	0.012	CbGeAlD
Tamoxifen—ESRRA—cardiac atrium—uterine fibroid	0.00138	0.0118	CbGeAlD
Tamoxifen—ESRRA—uterus—uterine fibroid	0.00137	0.0117	CbGeAlD
Tamoxifen—FMO3—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00136	0.015	CbGpPWpGaD
Tamoxifen—CYP1B1—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.00135	0.0149	CbGpPWpGaD
Tamoxifen—ESRRA—Nuclear Receptor transcription pathway—ESR1—uterine fibroid	0.00131	0.0144	CbGpPWpGaD
Tamoxifen—ESR2—Validated nuclear estrogen receptor alpha network—PGR—uterine fibroid	0.0013	0.0144	CbGpPWpGaD
Tamoxifen—Clomifene—ESR1—uterine fibroid	0.00128	0.199	CrCbGaD
Tamoxifen—CYP19A1—Ovarian Infertility Genes—PGR—uterine fibroid	0.00128	0.0141	CbGpPWpGaD
Tamoxifen—FMO3—mammalian vulva—uterine fibroid	0.00126	0.0108	CbGeAlD
Tamoxifen—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—uterine fibroid	0.00126	0.0139	CbGpPWpGaD
Tamoxifen—DHCR7—female reproductive system—uterine fibroid	0.00125	0.0107	CbGeAlD
Tamoxifen—ESRRA—female reproductive system—uterine fibroid	0.00123	0.0105	CbGeAlD
Tamoxifen—SULT1A1—Biological oxidations—CYP17A1—uterine fibroid	0.00122	0.0134	CbGpPWpGaD
Tamoxifen—SULT1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.0012	0.0132	CbGpPWpGaD
Tamoxifen—SIGMAR1—nipple—uterine fibroid	0.00115	0.0098	CbGeAlD
Tamoxifen—DHCR7—female gonad—uterine fibroid	0.00114	0.00974	CbGeAlD
Tamoxifen—FMO1—female gonad—uterine fibroid	0.00114	0.00974	CbGeAlD
Tamoxifen—DHCR7—vagina—uterine fibroid	0.00113	0.00968	CbGeAlD
Tamoxifen—FMO1—vagina—uterine fibroid	0.00113	0.00968	CbGeAlD
Tamoxifen—ESRRA—female gonad—uterine fibroid	0.00112	0.00959	CbGeAlD
Tamoxifen—ESRRA—vagina—uterine fibroid	0.00111	0.00953	CbGeAlD
Tamoxifen—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.00108	0.0119	CbGpPWpGaD
Tamoxifen—ESR2—Nuclear Receptors—ESR1—uterine fibroid	0.00106	0.0116	CbGpPWpGaD
Tamoxifen—FMO1—Biological oxidations—CYP17A1—uterine fibroid	0.00101	0.0111	CbGpPWpGaD
Tamoxifen—ESR1—Nuclear Receptors—PGR—uterine fibroid	0.000998	0.011	CbGpPWpGaD
Tamoxifen—FMO1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000996	0.011	CbGpPWpGaD
Tamoxifen—ESR2—Plasma membrane estrogen receptor signaling—ESR1—uterine fibroid	0.000994	0.0109	CbGpPWpGaD
Tamoxifen—ESR2—uterine cervix—uterine fibroid	0.000987	0.00844	CbGeAlD
Tamoxifen—SIGMAR1—myometrium—uterine fibroid	0.000983	0.00841	CbGeAlD
Tamoxifen—FMO3—vagina—uterine fibroid	0.000979	0.00837	CbGeAlD
Tamoxifen—ESR1—Nuclear signaling by ERBB4—PGR—uterine fibroid	0.000977	0.0108	CbGpPWpGaD
Tamoxifen—ESR2—smooth muscle tissue—uterine fibroid	0.000959	0.00821	CbGeAlD
Tamoxifen—ESR2—endometrium—uterine fibroid	0.000893	0.00764	CbGeAlD
Tamoxifen—ESR1—myometrium—uterine fibroid	0.000869	0.00743	CbGeAlD
Tamoxifen—CES1—female reproductive system—uterine fibroid	0.000854	0.00731	CbGeAlD
Tamoxifen—ESR2—Nuclear Receptor transcription pathway—ESR1—uterine fibroid	0.000835	0.00919	CbGpPWpGaD
Tamoxifen—CYP1A1—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.000832	0.00916	CbGpPWpGaD
Tamoxifen—ESR2—uterus—uterine fibroid	0.000823	0.00704	CbGeAlD
Tamoxifen—ESR1—Nuclear Receptor transcription pathway—PGR—uterine fibroid	0.000788	0.00868	CbGpPWpGaD
Tamoxifen—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000781	0.0086	CbGpPWpGaD
Tamoxifen—CYP1A2—nipple—uterine fibroid	0.000781	0.00668	CbGeAlD
Tamoxifen—CES1—female gonad—uterine fibroid	0.000777	0.00665	CbGeAlD
Tamoxifen—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000771	0.00849	CbGpPWpGaD
Tamoxifen—CYP1A1—nipple—uterine fibroid	0.00077	0.00659	CbGeAlD
Tamoxifen—SIGMAR1—uterine cervix—uterine fibroid	0.000765	0.00654	CbGeAlD
Tamoxifen—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000752	0.00828	CbGpPWpGaD
Tamoxifen—SIGMAR1—smooth muscle tissue—uterine fibroid	0.000743	0.00636	CbGeAlD
Tamoxifen—CYP1B1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000742	0.00817	CbGpPWpGaD
Tamoxifen—ESR2—female reproductive system—uterine fibroid	0.00074	0.00633	CbGeAlD
Tamoxifen—SIGMAR1—decidua—uterine fibroid	0.000729	0.00623	CbGeAlD
Tamoxifen—FMO3—Biological oxidations—CYP17A1—uterine fibroid	0.000722	0.00795	CbGpPWpGaD
Tamoxifen—FMO3—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000712	0.00784	CbGpPWpGaD
Tamoxifen—CYP1B1—smooth muscle tissue—uterine fibroid	0.000707	0.00605	CbGeAlD
Tamoxifen—CYP19A1—endometrium—uterine fibroid	0.000704	0.00602	CbGeAlD
Tamoxifen—SIGMAR1—urethra—uterine fibroid	0.000703	0.00601	CbGeAlD
Tamoxifen—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—uterine fibroid	0.000696	0.00766	CbGpPWpGaD
Tamoxifen—ABCG2—myometrium—uterine fibroid	0.000696	0.00595	CbGeAlD
Tamoxifen—CYP1B1—decidua—uterine fibroid	0.000693	0.00593	CbGeAlD
Tamoxifen—SIGMAR1—endometrium—uterine fibroid	0.000692	0.00592	CbGeAlD
Tamoxifen—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000678	0.00747	CbGpPWpGaD
Tamoxifen—ESR1—uterine cervix—uterine fibroid	0.000676	0.00578	CbGeAlD
Tamoxifen—ESR2—female gonad—uterine fibroid	0.000673	0.00576	CbGeAlD
Tamoxifen—CYP2A6—vagina—uterine fibroid	0.000672	0.00575	CbGeAlD
Tamoxifen—CYP3A7—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000669	0.00737	CbGpPWpGaD
Tamoxifen—SIGMAR1—mammalian vulva—uterine fibroid	0.000669	0.00572	CbGeAlD
Tamoxifen—ESR2—vagina—uterine fibroid	0.000669	0.00572	CbGeAlD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine fibroid	0.000657	0.00724	CbGpPWpGaD
Tamoxifen—ESR1—smooth muscle tissue—uterine fibroid	0.000657	0.00562	CbGeAlD
Tamoxifen—CYP19A1—uterus—uterine fibroid	0.000648	0.00555	CbGeAlD
Tamoxifen—ESR1—decidua—uterine fibroid	0.000644	0.00551	CbGeAlD
Tamoxifen—SIGMAR1—cardiac atrium—uterine fibroid	0.000641	0.00548	CbGeAlD
Tamoxifen—SIGMAR1—uterus—uterine fibroid	0.000638	0.00545	CbGeAlD
Tamoxifen—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000633	0.00697	CbGpPWpGaD
Tamoxifen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000622	0.00685	CbGpPWpGaD
Tamoxifen—CYP2A6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000614	0.00676	CbGpPWpGaD
Tamoxifen—ESR1—endometrium—uterine fibroid	0.000612	0.00523	CbGeAlD
Tamoxifen—CYP1B1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00061	0.00671	CbGpPWpGaD
Tamoxifen—CYP1B1—uterus—uterine fibroid	0.000606	0.00518	CbGeAlD
Tamoxifen—UGT1A4—Biological oxidations—CYP17A1—uterine fibroid	0.000605	0.00666	CbGpPWpGaD
Tamoxifen—UGT1A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000596	0.00657	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—HPSE2—uterine fibroid	0.000591	0.0065	CbGpPWpGaD
Tamoxifen—CYP19A1—female reproductive system—uterine fibroid	0.000583	0.00499	CbGeAlD
Tamoxifen—SULT1A1—Metabolism—HPSE2—uterine fibroid	0.00058	0.00638	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000568	0.00625	CbGpPWpGaD
Tamoxifen—ESR1—uterus—uterine fibroid	0.000564	0.00482	CbGeAlD
Tamoxifen—EBP—Metabolism—HPSE2—uterine fibroid	0.00056	0.00617	CbGpPWpGaD
Tamoxifen—ABCC2—female reproductive system—uterine fibroid	0.000556	0.00476	CbGeAlD
Tamoxifen—CYP3A7—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00055	0.00605	CbGpPWpGaD
Tamoxifen—CYP1B1—female reproductive system—uterine fibroid	0.000545	0.00466	CbGeAlD
Tamoxifen—ABCG2—uterine cervix—uterine fibroid	0.000542	0.00463	CbGeAlD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000539	0.00593	CbGpPWpGaD
Tamoxifen—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.000531	0.00584	CbGpPWpGaD
Tamoxifen—CYP19A1—female gonad—uterine fibroid	0.00053	0.00454	CbGeAlD
Tamoxifen—SIGMAR1—female gonad—uterine fibroid	0.000521	0.00446	CbGeAlD
Tamoxifen—SIGMAR1—vagina—uterine fibroid	0.000518	0.00443	CbGeAlD
Tamoxifen—ABCG2—decidua—uterine fibroid	0.000516	0.00441	CbGeAlD
Tamoxifen—CYP1A1—uterine cervix—uterine fibroid	0.000514	0.0044	CbGeAlD
Tamoxifen—ESRRA—Generic Transcription Pathway—MED12—uterine fibroid	0.000512	0.00564	CbGpPWpGaD
Tamoxifen—ESR1—female reproductive system—uterine fibroid	0.000507	0.00433	CbGeAlD
Tamoxifen—CYP2A6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000504	0.00555	CbGpPWpGaD
Tamoxifen—CYP2C8—endometrium—uterine fibroid	0.000504	0.00431	CbGeAlD
Tamoxifen—CYP3A5—uterine cervix—uterine fibroid	0.000503	0.0043	CbGeAlD
Tamoxifen—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000502	0.00552	CbGpPWpGaD
Tamoxifen—ABCG2—urethra—uterine fibroid	0.000498	0.00426	CbGeAlD
Tamoxifen—CYP1B1—female gonad—uterine fibroid	0.000496	0.00424	CbGeAlD
Tamoxifen—CYP2B6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000495	0.00545	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000492	0.00541	CbGpPWpGaD
Tamoxifen—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000491	0.00541	CbGpPWpGaD
Tamoxifen—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00049	0.0054	CbGpPWpGaD
Tamoxifen—ABCG2—endometrium—uterine fibroid	0.00049	0.00419	CbGeAlD
Tamoxifen—CYP2E1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000485	0.00534	CbGpPWpGaD
Tamoxifen—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000484	0.00533	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—HPSE2—uterine fibroid	0.000482	0.0053	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000476	0.00524	CbGpPWpGaD
Tamoxifen—ABCG2—mammalian vulva—uterine fibroid	0.000474	0.00405	CbGeAlD
Tamoxifen—CYP1A1—urethra—uterine fibroid	0.000473	0.00404	CbGeAlD
Tamoxifen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000463	0.0051	CbGpPWpGaD
Tamoxifen—ESR1—female gonad—uterine fibroid	0.000461	0.00394	CbGeAlD
Tamoxifen—ESR1—vagina—uterine fibroid	0.000458	0.00392	CbGeAlD
Tamoxifen—CYP1A1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000457	0.00503	CbGpPWpGaD
Tamoxifen—ABCG2—uterus—uterine fibroid	0.000451	0.00386	CbGeAlD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000451	0.00496	CbGpPWpGaD
Tamoxifen—CYP1A1—mammalian vulva—uterine fibroid	0.00045	0.00385	CbGeAlD
Tamoxifen—ESRRA—Metabolism—HPSE2—uterine fibroid	0.000448	0.00493	CbGpPWpGaD
Tamoxifen—CYP2C19—vagina—uterine fibroid	0.000432	0.0037	CbGeAlD
Tamoxifen—CYP2E1—urethra—uterine fibroid	0.000431	0.00369	CbGeAlD
Tamoxifen—CYP1A1—cardiac atrium—uterine fibroid	0.000431	0.00368	CbGeAlD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000431	0.00474	CbGpPWpGaD
Tamoxifen—CYP1A1—uterus—uterine fibroid	0.000429	0.00367	CbGeAlD
Tamoxifen—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000425	0.00468	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—PGR—uterine fibroid	0.000424	0.00467	CbGpPWpGaD
Tamoxifen—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000419	0.00461	CbGpPWpGaD
Tamoxifen—CYP2C8—female reproductive system—uterine fibroid	0.000417	0.00357	CbGeAlD
Tamoxifen—CYP2B6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000407	0.00448	CbGpPWpGaD
Tamoxifen—CYP2E1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000398	0.00439	CbGpPWpGaD
Tamoxifen—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000398	0.00438	CbGpPWpGaD
Tamoxifen—CYP1A1—female reproductive system—uterine fibroid	0.000385	0.00329	CbGeAlD
Tamoxifen—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000379	0.00417	CbGpPWpGaD
Tamoxifen—CYP2C8—vagina—uterine fibroid	0.000377	0.00323	CbGeAlD
Tamoxifen—CYP1A1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000376	0.00413	CbGpPWpGaD
Tamoxifen—CYP2B6—female reproductive system—uterine fibroid	0.000374	0.0032	CbGeAlD
Tamoxifen—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000374	0.00412	CbGpPWpGaD
Tamoxifen—CYP2C9—female reproductive system—uterine fibroid	0.000371	0.00317	CbGeAlD
Tamoxifen—ABCG2—female gonad—uterine fibroid	0.000369	0.00316	CbGeAlD
Tamoxifen—ABCG2—vagina—uterine fibroid	0.000367	0.00314	CbGeAlD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00036	0.00397	CbGpPWpGaD
Tamoxifen—CYP2E1—female reproductive system—uterine fibroid	0.000351	0.003	CbGeAlD
Tamoxifen—CYP1A1—female gonad—uterine fibroid	0.000351	0.003	CbGeAlD
Tamoxifen—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000349	0.00384	CbGpPWpGaD
Tamoxifen—CYP1A1—vagina—uterine fibroid	0.000348	0.00298	CbGeAlD
Tamoxifen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000346	0.00381	CbGpPWpGaD
Tamoxifen—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000344	0.00379	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—HPSE2—uterine fibroid	0.000344	0.00379	CbGpPWpGaD
Tamoxifen—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000344	0.00379	CbGpPWpGaD
Tamoxifen—ABCB1—myometrium—uterine fibroid	0.000343	0.00294	CbGeAlD
Tamoxifen—CYP3A5—female gonad—uterine fibroid	0.000343	0.00293	CbGeAlD
Tamoxifen—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000341	0.00376	CbGpPWpGaD
Tamoxifen—CYP1A1—PPARA activates gene expression—MED12—uterine fibroid	0.000341	0.00375	CbGpPWpGaD
Tamoxifen—CYP3A5—vagina—uterine fibroid	0.000341	0.00291	CbGeAlD
Tamoxifen—CYP2B6—vagina—uterine fibroid	0.000339	0.0029	CbGeAlD
Tamoxifen—CYP19A1—Biological oxidations—CYP17A1—uterine fibroid	0.000336	0.0037	CbGpPWpGaD
Tamoxifen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—uterine fibroid	0.000334	0.00367	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—TNRC6B—uterine fibroid	0.000332	0.00366	CbGpPWpGaD
Tamoxifen—CYP19A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000332	0.00365	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—PGR—uterine fibroid	0.000329	0.00362	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—MED12—uterine fibroid	0.000326	0.00359	CbGpPWpGaD
Tamoxifen—CYP1B1—Biological oxidations—CYP17A1—uterine fibroid	0.000324	0.00357	CbGpPWpGaD
Tamoxifen—CYP1B1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00032	0.00352	CbGpPWpGaD
Tamoxifen—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000307	0.00338	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000303	0.00333	CbGpPWpGaD
Tamoxifen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000295	0.00325	CbGpPWpGaD
Tamoxifen—CYP3A7—Biological oxidations—CYP17A1—uterine fibroid	0.000292	0.00322	CbGpPWpGaD
Tamoxifen—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000292	0.00321	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00029	0.0032	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—HPSE2—uterine fibroid	0.000289	0.00318	CbGpPWpGaD
Tamoxifen—CYP3A7—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000288	0.00317	CbGpPWpGaD
Tamoxifen—CYP3A4—female reproductive system—uterine fibroid	0.000283	0.00242	CbGeAlD
Tamoxifen—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000283	0.00311	CbGpPWpGaD
Tamoxifen—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00028	0.00309	CbGpPWpGaD
Tamoxifen—CYP2D6—female reproductive system—uterine fibroid	0.000278	0.00238	CbGeAlD
Tamoxifen—ESR2—Generic Transcription Pathway—PGR—uterine fibroid	0.00027	0.00297	CbGpPWpGaD
Tamoxifen—CYP2A6—Biological oxidations—CYP17A1—uterine fibroid	0.000268	0.00295	CbGpPWpGaD
Tamoxifen—ABCB1—uterine cervix—uterine fibroid	0.000267	0.00228	CbGeAlD
Tamoxifen—ABCB1—decidua—uterine fibroid	0.000254	0.00218	CbGeAlD
Tamoxifen—CYP2D6—female gonad—uterine fibroid	0.000253	0.00216	CbGeAlD
Tamoxifen—DHCR7—Metabolism—MED12—uterine fibroid	0.000253	0.00279	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—MED12—uterine fibroid	0.000248	0.00273	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MED12—uterine fibroid	0.000247	0.00271	CbGpPWpGaD
Tamoxifen—ABCB1—urethra—uterine fibroid	0.000245	0.0021	CbGeAlD
Tamoxifen—ABCB1—endometrium—uterine fibroid	0.000242	0.00207	CbGeAlD
Tamoxifen—EBP—Metabolism—MED12—uterine fibroid	0.00024	0.00264	CbGpPWpGaD
Tamoxifen—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000239	0.00264	CbGpPWpGaD
Tamoxifen—ABCB1—mammalian vulva—uterine fibroid	0.000234	0.002	CbGeAlD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.00023	0.00253	CbGpPWpGaD
Tamoxifen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000228	0.00251	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—ESR1—uterine fibroid	0.000227	0.00249	CbGpPWpGaD
Tamoxifen—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000225	0.00248	CbGpPWpGaD
Tamoxifen—ABCB1—uterus—uterine fibroid	0.000223	0.0019	CbGeAlD
Tamoxifen—CYP2B6—Biological oxidations—CYP17A1—uterine fibroid	0.000216	0.00238	CbGpPWpGaD
Tamoxifen—CYP2B6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000213	0.00235	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—HPSE2—uterine fibroid	0.000213	0.00234	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CYP17A1—uterine fibroid	0.000212	0.00233	CbGpPWpGaD
Tamoxifen—CYP2E1—Biological oxidations—CYP17A1—uterine fibroid	0.000212	0.00233	CbGpPWpGaD
Tamoxifen—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.000211	0.00232	CbGpPWpGaD
Tamoxifen—CYP2E1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000209	0.0023	CbGpPWpGaD
Tamoxifen—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000208	0.00229	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—CYP17A1—uterine fibroid	0.000208	0.00229	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—TNRC6B—uterine fibroid	0.000206	0.00227	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—MED12—uterine fibroid	0.000206	0.00227	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000205	0.00225	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—PGR—uterine fibroid	0.000204	0.00225	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CYP17A1—uterine fibroid	0.000201	0.00221	CbGpPWpGaD
Tamoxifen—ABCB1—female reproductive system—uterine fibroid	0.0002	0.00171	CbGeAlD
Tamoxifen—CYP1A1—Biological oxidations—CYP17A1—uterine fibroid	0.0002	0.0022	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000197	0.00217	CbGpPWpGaD
Tamoxifen—CYP1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000197	0.00217	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000193	0.00213	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—MED12—uterine fibroid	0.000192	0.00211	CbGpPWpGaD
Tamoxifen—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000185	0.00203	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.000183	0.00201	CbGpPWpGaD
Tamoxifen—ABCB1—female gonad—uterine fibroid	0.000182	0.00156	CbGeAlD
Tamoxifen—ABCB1—vagina—uterine fibroid	0.000181	0.00155	CbGeAlD
Tamoxifen—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00018	0.00199	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CYP17A1—uterine fibroid	0.000173	0.0019	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000171	0.00188	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MED12—uterine fibroid	0.000164	0.00181	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—CYP17A1—uterine fibroid	0.000163	0.0018	CbGpPWpGaD
Tamoxifen—CYP2C19—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000161	0.00177	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CYP17A1—uterine fibroid	0.00016	0.00177	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—HPSE2—uterine fibroid	0.00016	0.00177	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MED12—uterine fibroid	0.000157	0.00173	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—HPSE2—uterine fibroid	0.000155	0.0017	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000154	0.0017	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	0.00015	0.00165	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	0.000149	0.00164	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000149	0.00164	CbGpPWpGaD
Tamoxifen—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000148	0.00163	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—MED12—uterine fibroid	0.000147	0.00162	CbGpPWpGaD
Tamoxifen—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000147	0.00162	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—ESR1—uterine fibroid	0.000144	0.00159	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—HPSE2—uterine fibroid	0.000141	0.00155	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—HPSE2—uterine fibroid	0.000139	0.00153	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—PGR—uterine fibroid	0.000136	0.0015	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—TNRC6B—uterine fibroid	0.000131	0.00145	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—PGR—uterine fibroid	0.00013	0.00143	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000129	0.00142	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—HPSE2—uterine fibroid	0.000128	0.00141	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—CYP17A1—uterine fibroid	0.000127	0.0014	CbGpPWpGaD
Tamoxifen—CYP1A2—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000125	0.00138	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000124	0.00137	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—MED12—uterine fibroid	0.000124	0.00136	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CYP17A1—uterine fibroid	0.000123	0.00136	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—ESR1—uterine fibroid	0.000109	0.0012	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CYP17A1—uterine fibroid	0.000103	0.00114	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—HPSE2—uterine fibroid	0.000103	0.00113	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—HPSE2—uterine fibroid	0.000101	0.00111	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—HPSE2—uterine fibroid	0.000101	0.00111	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	9.82e-05	0.00108	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	9.68e-05	0.00107	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—HPSE2—uterine fibroid	9.52e-05	0.00105	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	9.15e-05	0.00101	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—MED12—uterine fibroid	9.11e-05	0.001	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HPSE2—uterine fibroid	8.73e-05	0.000961	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	8.39e-05	0.000924	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MED12—uterine fibroid	7.91e-05	0.000871	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HPSE2—uterine fibroid	7.79e-05	0.000857	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	7.75e-05	0.000853	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	7.66e-05	0.000843	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CYP17A1—uterine fibroid	7.62e-05	0.000839	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HPSE2—uterine fibroid	7.6e-05	0.000837	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	7.49e-05	0.000825	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HPSE2—uterine fibroid	7.16e-05	0.000789	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HPSE2—uterine fibroid	7.1e-05	0.000782	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	7.02e-05	0.000773	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—ESR1—uterine fibroid	6.94e-05	0.000764	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—MED12—uterine fibroid	6.87e-05	0.000757	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	6.83e-05	0.000752	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—TNRC6B—uterine fibroid	6.62e-05	0.000729	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—MED12—uterine fibroid	6.62e-05	0.000729	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—PGR—uterine fibroid	6.56e-05	0.000722	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	6.27e-05	0.00069	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HPSE2—uterine fibroid	6.07e-05	0.000668	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—MED12—uterine fibroid	6.02e-05	0.000663	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—MED12—uterine fibroid	5.97e-05	0.000657	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	5.84e-05	0.000642	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CYP17A1—uterine fibroid	5.75e-05	0.000633	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	5.72e-05	0.000629	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CYP17A1—uterine fibroid	5.54e-05	0.00061	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—MED12—uterine fibroid	5.47e-05	0.000602	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP17A1—uterine fibroid	5.04e-05	0.000555	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP17A1—uterine fibroid	5e-05	0.00055	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	4.88e-05	0.000538	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HPSE2—uterine fibroid	4.68e-05	0.000516	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP17A1—uterine fibroid	4.58e-05	0.000504	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MED12—uterine fibroid	4.41e-05	0.000486	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MED12—uterine fibroid	4.32e-05	0.000476	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MED12—uterine fibroid	4.31e-05	0.000475	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TNRC6B—uterine fibroid	4.31e-05	0.000474	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PGR—uterine fibroid	4.26e-05	0.000469	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MED12—uterine fibroid	4.08e-05	0.000449	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MED12—uterine fibroid	3.74e-05	0.000411	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP17A1—uterine fibroid	3.69e-05	0.000407	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP17A1—uterine fibroid	3.62e-05	0.000398	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP17A1—uterine fibroid	3.61e-05	0.000398	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP17A1—uterine fibroid	3.41e-05	0.000376	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MED12—uterine fibroid	3.34e-05	0.000367	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MED12—uterine fibroid	3.26e-05	0.000358	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP17A1—uterine fibroid	3.13e-05	0.000344	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MED12—uterine fibroid	3.07e-05	0.000338	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MED12—uterine fibroid	3.04e-05	0.000335	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP17A1—uterine fibroid	2.79e-05	0.000307	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP17A1—uterine fibroid	2.73e-05	0.0003	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MED12—uterine fibroid	2.6e-05	0.000286	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP17A1—uterine fibroid	2.57e-05	0.000283	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP17A1—uterine fibroid	2.55e-05	0.00028	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP17A1—uterine fibroid	2.18e-05	0.000239	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MED12—uterine fibroid	2.01e-05	0.000221	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP17A1—uterine fibroid	1.68e-05	0.000185	CbGpPWpGaD
